Karyopharm Therapeutics (KPTI) Wild Ride Occurring as M&A Speculation Proved Wrong Amid Executive Departure - RBC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 0.52 -0.03 (5.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.55 | 52 Week High | $19.41 | |||
| Open | $0.54 | 52 Week Low | $4.83 | |||
| Day High | $0.56 | P/E | N/A | |||
| Day Low | $0.44 | EPS | $-2.74 | |||
| Volume | 1,963,546 | |||||
